Andelyn Biosciences

Andelyn Biosciences is a biotechnology company based in Columbus, Ohio, with a workforce of 225 employees. The company generated $100 million in revenue. Andelyn Biosciences specializes in gene therapy, providing services such as viral vector process and analytical development, GMP drug substance manufacturing, and GMP plasmid process development. Their client base includes companies seeking to develop and manufacture innovative gene therapies. Andelyn Biosciences boasts over 20 years of experience in viral vector and vaccine manufacturing, offering clients access to a team of globally recognized experts. The company has a proven track record of success, having produced GMP material for over 75 worldwide clinical trials and more than 450 cGMP clinical batches. Their 180,000 sq ft facility is equipped with 16 upstream production suites, enabling them to accommodate both new and tech transferred programs. For more information or to connect with Andelyn Biosciences, please visit their website at andelynbio.com.